Study explores older adults' perspectives on proactive deprescribing

Background and goal: This study explored older adults' perspectives on proactive deprescribing, identified barriers and enablers, and developed a typology of patient attitudes to inform patient-centered deprescribing interventions.

Study approach: In this qualitative study, researchers conducted semi structured interviews with 20 patients in Japan aged 65 years or older who were receiving 5 or more oral medications. 

Main results:

Enablers

  • Negative valuation of medication: patients noted pill burden, possible harm and past success in stopping drugs.

  • Proactive decision making preference: a few patients wanted an active role and even started deprescribing talks.

  • Openness based on trust in the prescriber: many said they would cut back if a trusted clinician suggested it.

Barriers

  • Positive perspective on medication: satisfaction with current drugs or high expectations kept regimens unchanged.

  • Passive involvement and low perceived capability: patients deferred to doctors and felt unable to ask about deprescribing.

  • Caution driven by fear of change or comfort with the status quo: worry about symptom return discouraged stopping pills.

The researchers also developed a new typology with five types of patients: indifferent, satisfied and risk-averse, compliant, fearful but passive, and proactive.

Why it matters: The findings from this study show that patients vary in their readiness to cut back on medications and underscore the importance of tailoring deprescribing discussions to each patient.

Source:
Journal reference:

le, K., et al. (2025) Proactive Deprescribing Among Older Adults With Polypharmacy: Barriers and Enablers. The Annals of Family Medicine. doi.org/10.1370/afm.240363.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Herpes virus infection linked to higher Alzheimer’s risk, study shows antiherpetic drugs may help